Related Experiment Videos

Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee

Chaitra S Ujjani¹, Bruce D Cheson¹

¹Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC, USA.

British Journal of Haematology

|July 9, 2016

Abstract

No abstract available in PubMed .

Keywords:

bone marrow biopsy lymphoma positron emission tomography-computerized tomography stage

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia.

Blood advances·2026

Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.

The Lancet. Haematology·2026

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study.

Blood advances·2026

Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2025

Long-term follow-up of dose-dense brentuximab vedotin, ifosfamide, carboplatin and etoposide in second-line treatment of relapsed/refractory classical Hodgkin lymphoma.

British journal of haematology·2025

See all related articles